Related Experiment Video
Updated: Feb 14, 2026
A Melanoma Patient-Derived Xenograft Model
Published on: May 20, 2019
Drug Therapy for Melanoma: Current Updates and Future Prospects
1Department of Geriatric and Environmental Dermatology, Graduate School of Medical Sciences, Nagoya City University, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan.
Abstract:
Melanoma was once considered 'incurable'; however, drug therapy for the condition has dramatically transformed with the advent of immune checkpoint inhibitors and molecular targeted therapies. In this review, we summarize the published literature on melanoma drug therapy, presenting the current landscape of melanoma treatments, and discuss potential future transformations in melanoma therapy. Although the prognosis of advanced-stage melanoma had been extremely poor in the past, new-age immunotherapy has made long-term survival possible. Several immunotherapies and their combinations, as well as personalized vaccines, cell therapies, and intratumoral agents, have been tested with success; however, adverse toxicities have also been detected. Therefore, patient selection and management are critical. Furthermore, new approaches to overcome the limitations of the current treatments are also being developed. To implement these therapies clinically, guideline-recommended treatment algorithms should be followed while optimizing the therapies by considering factors such as presence of BRAF mutations which may lead to treatment resistance, increased disease burden/progression rate, toxicity tolerance, and the presence of brain metastases. In practice, the choice of the initial therapy should depend on the patient, leading to personalized therapy and minimal adverse effects.
Insights
Melanoma drug therapy has advanced significantly with immunotherapy and targeted treatments, improving long-term survival for advanced stages. Personalized patient selection and management are crucial for optimizing these effective melanoma treatments.
Area of Science:
- Oncology
- Dermatology
- Immunology
Background:
- Melanoma treatment has evolved from 'incurable' to manageable with modern therapies.
- Advanced-stage melanoma historically had a poor prognosis, but new treatments offer hope.
Purpose of the Study:
- To review current melanoma drug therapies, including immunotherapy and targeted treatments.
- To discuss future directions and challenges in melanoma treatment.
- To highlight the importance of personalized medicine in melanoma care.
Main Methods:
- Comprehensive literature review of published studies on melanoma drug therapy.
- Analysis of current treatment landscape, including immunotherapies, targeted therapies, vaccines, cell therapies, and intratumoral agents.
- Discussion of factors influencing treatment selection and optimization.
Main Results:
- Immune checkpoint inhibitors and molecular targeted therapies have transformed melanoma treatment.
- Immunotherapy has enabled long-term survival in advanced melanoma.
- Adverse toxicities are associated with new treatments, necessitating careful patient selection and management.
Conclusions:
- Personalized therapy, guided by patient-specific factors like BRAF mutations and metastases, is key to optimizing melanoma treatment.
- Guideline-recommended algorithms should be followed, with adjustments for individual patient needs to minimize adverse effects.
- Ongoing research aims to overcome current treatment limitations and further improve melanoma outcomes.
More Related Videos
08:22Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
Published on: October 7, 2017
10:11Updated Technique for Reliable, Easy, and Tolerated Transcranial Electrical Stimulation Including Transcranial Direct Current Stimulation
Published on: January 3, 2020
Related Concept Videos
01:28Drug Therapy
Antianxiety Medications
01:26Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
00:59Gene Therapy
01:10Electrical Current